Viewing StudyNCT06172127



Ignite Creation Date: 2024-05-06 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06172127
Status: RECRUITING
Last Update Posted: 2023-12-15
First Post: 2023-11-28

Brief Title: PHESGO Maintenance After T-DXd Short Induction for HER2 Unresectable Locally Recurrent or Metastatic Breast Cancer
Sponsor: MedSIR
Organization: MedSIR

Conditions & Keywords Data

Conditions:
Name
HER2-positive Breast Cancer
Keywords:
Name View
T-DXd View
HER2 Breast Cancer View
Unresectable Locally Advanced Breast Cancer View
Metastatic Breast Cancer View
PHESGO View
Pertuzumab and Trastuzumab View